DVA vs HSIC — Key Metrics

Metric DVA (DAVITA INC) HSIC (HENRY SCHEIN INC)
Price161.7985.69
Market Cap10.18 Billion9.47 Billion
P/E (TTM)11.7223.29
P/B (Quarterly)-20.5712.887
P/S (TTM)0.720.69
Net Profit Margin (TTM)6.53.1
Gross Margin (TTM)32.331.6
ROE (TTM)-133.213.1
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

DAVITA INC
vs
 
HENRY SCHEIN INC
 
DAVITA INC
vs
 
HENRY SCHEIN INC
Performance Comparison
AI Model Recommendation
DVA · DAVITA INC

Outperform

51
UnderperformOutperform
HSIC · HENRY SCHEIN INC

Greatly Outperform

61
UnderperformOutperform
Recommendation Summary

Stock DVA is projected to outperform the market, stock HSIC is projected to greatly outperform the market. Upfront Recommendation: HSIC.

Financial Metrics
Prices delayed ~15 min
DVA Metrics HSIC
$161.79 Price $85.69
— Market Capitalization —
11.72 Price to Earnings Ratio 23.29
0.72 Price to Sales 0.69
7.87 Price to FCF Ratio 18.94
2.23 Price to Gross Profit 2.18
2.5 Price to Current Assets 1.98

DVA vs HSIC at a glance

Davita INC (DVA) and Henry Schein INC (HSIC) are both in the Healthcare sector. They are similar in size: $10.2 billion and $9.5 billion in market value.

On trailing-twelve-month figures, DVA trades at 11.7 times trailing earnings and HSIC at 23.3; net profit margins are 6.5% and 3.1%.

The Upfront Investment model currently rates DVA Outperform and HSIC Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.